Marjorie Robin is an experienced professional in pharmacovigilance and quality management, currently serving as the Transversal Corporate Process Owner Inspection & Audit at UCB Biopharma since August 2024. With a robust background in pharmacovigilance, Marjorie has held various roles including Pharmacovigilance Quality Improvement Partner at Strand Associates Consulting, Senior Manager of Pharmacovigilance Audit & Inspection at Bristol Myers Squibb, and actively contributed to UCB in several capacities over a 12-year span. Marjorie's earlier experience includes positions as a Clinical Data Coordinator at Msource Medical Development and Data Manager at EORTC, as well as research assistant roles at prestigious institutions, culminating in a DES in Toxicology from Université catholique de Louvain.